Re: I believe the big/long wait
|
2
|
Resverlogix Corp.
|
Aug 25, 2023 12:28PM
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
2
|
Zenith Epigenetics
|
Feb 11, 2019 10:41PM
|
Re: Pan versus Selective Inhibitors....I need analogies
|
2
|
Resverlogix Corp.
|
Nov 22, 2017 06:20PM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 05:09PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 24, 2019 01:45AM
|
Re: To Be or Not to Be?
|
2
|
Resverlogix Corp.
|
Aug 11, 2021 10:11PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
2
|
Resverlogix Corp.
|
Mar 27, 2022 01:58AM
|
Re: How should the company be actng just about now,..
|
2
|
Resverlogix Corp.
|
Jun 24, 2019 02:57PM
|
Re: Resverlogix Publications, Presentations and Abstracts
|
2
|
Resverlogix Corp.
|
Sep 27, 2017 10:19AM
|
Re: ClinicalTrials.Gov updated....calling the science geeks
|
2
|
Resverlogix Corp.
|
Oct 21, 2017 03:24AM
|
Re: Biotech Showcase January 8-10, 2018
|
2
|
Zenith Epigenetics
|
Jan 08, 2018 02:02AM
|
Re: Exposure in Motley Fool....
|
2
|
Resverlogix Corp.
|
Oct 08, 2019 07:04PM
|
Re: What the media is saying now...
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 04:53PM
|
Wouldn't it be cool if...
|
2
|
Resverlogix Corp.
|
Jul 08, 2019 10:57AM
|
Welcome To The RVX Hub - Newb1000
|
2
|
Resverlogix Corp.
|
Oct 27, 2019 11:54PM
|
Re: wideout,Tada etc…
|
2
|
Resverlogix Corp.
|
Sep 14, 2023 12:45PM
|
Re: NEJM Editorial on REDUCE-IT
|
2
|
Resverlogix Corp.
|
Nov 16, 2018 04:18PM
|
Re: From General360 On SH....Hepalink halted pending asset acquisition
|
2
|
Resverlogix Corp.
|
Jun 05, 2017 03:18PM
|
Re: Apabetalone......a Calculated Risk
|
2
|
Resverlogix Corp.
|
Apr 09, 2019 02:42AM
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
2
|
Resverlogix Corp.
|
Oct 06, 2019 04:51AM
|